학술논문
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
Document Type
Article
Author
Rogé, M.; Rio, E.; Guimas, V.; Libois, V.; Supiot, S.; Pointreau, Y.; Ruffier, A.; Denis, F.; Sargos, P.; Meyer, E.; Schick, U.; Chasseray, M.; Hasbini, A.; Bera, G.; Quivrin, M.; Martin, E.; Latorzeff, I.; Pommier, P.; Leroy, T.; Ronchin, P.; Lepinoy, A.; Grand, A.; Cartier, L.; Didas, O.; Blanc-Lapierre, A.
Source
In: Clinical and Translational Radiation Oncology . (Clinical and Translational Radiation Oncology, May 2023, 40)
Subject
Language
English
ISSN
24056308